|
|
 |
 |
Co-Chairs |
David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Associate Director for Clinical Research
Director, Thoracic Oncology Program
UC Davis Cancer Center
Sacramento, CA
|
|
Rafael Rosell, MD, PhD
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catalan Institute of Oncology
Hospital Germans Trias I Pujol
Barcelona, Spain |
Other Expert Faculty
Daniel F. Hayes, MD
Professor, Department of Internal Medicine
Co-Director, Breast Care Center
Clinical Director, Breast Oncology Program
University of Michigan
Comprehensive Cancer Center
Ann Arbor, MI
|
|
Soonmyung Paik, MD
Director, Division of Pathology
National Surgical Adjuvant Breast
and Bowel Project (NSABP)
Pittsburgh, PA
|
Edith A. Perez, MD
Serene M. and Frances C. Durling Professor of Medicine
Division of Hematology/Oncology
Director, Clinical Investigations
Director, Breast Cancer Program
Chair, Breast Committee for the North Central Cancer Treatment Group (NCCTG)
Mayo Clinic
Jacksonville, FL
|
|
Lajos Pusztai, MD, DPhil, FACP
Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas
M. D. Anderson Cancer Center
Houston, TX
|
|
|
|
|
|
|
| DISCLOSURE STATEMENT |
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Oncology Learning Center (OLC) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an OLC-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Note: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.
|
| FACULTY/STAFF DISCLOSURE |
Coming Soon.
|
| DISCLOSURE OF UNLABELED USE |
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Oncology Learning Center does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Oncology Learning Center. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. |
| DISCLAIMER |
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
|
|
|
